Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NMDA Receptor Modulation for Hyperarousal in PTSD

NCT03166501 is registered in ClinicalTrials.gov with Baylor College of Medicine as lead sponsor.

NCT NCT03166501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03166501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NMDA Receptor Modulation for Hyperarousal in PTSD
Lead sponsor
Baylor College of Medicine
Phase
Phase 1
Overall status
Completed
Start date
September 1, 2018
Completion date
November 14, 2019
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, post traumatic stress disorder